NEW YORK, NY--(Marketwire - November 10, 2008) - China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) (“China Aoxing”), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced the newly appointed Board of Directors and the election of a new Chief Financial Officer. Comprised of individuals from both the US and China, the Board reflects a wide range of industry experience and expertise, and represents another important step toward developing China Aoxing into a world-class specialty pharmaceutical company. The newly appointed board and the new CFO have assumed their positions effective immediately.
